nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SCN5A—dilated cardiomyopathy	0.319	0.635	CbGaD
Quinidine—SLC22A5—dilated cardiomyopathy	0.184	0.366	CbGaD
Quinidine—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.0674	0.213	CbGbCtD
Quinidine—ABCC2—Spironolactone—dilated cardiomyopathy	0.0559	0.177	CbGbCtD
Quinidine—SLC22A5—Furosemide—dilated cardiomyopathy	0.0491	0.155	CbGbCtD
Quinidine—SLC22A8—Furosemide—dilated cardiomyopathy	0.0401	0.127	CbGbCtD
Quinidine—ABCC2—Furosemide—dilated cardiomyopathy	0.0382	0.121	CbGbCtD
Quinidine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0269	0.085	CbGbCtD
Quinidine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0207	0.0654	CbGbCtD
Quinidine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0182	0.0576	CbGbCtD
Quinidine—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0171	0.257	CbGeAlD
Quinidine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0105	0.158	CbGeAlD
Quinidine—SCN5A—endocardium—dilated cardiomyopathy	0.00882	0.133	CbGeAlD
Quinidine—SCN5A—sinoatrial node—dilated cardiomyopathy	0.00836	0.126	CbGeAlD
Quinidine—KCNH2—endocardium—dilated cardiomyopathy	0.00542	0.0815	CbGeAlD
Quinidine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00441	0.0662	CbGeAlD
Quinidine—Quinidine barbiturate—SCN5A—dilated cardiomyopathy	0.00281	0.685	CrCbGaD
Quinidine—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00226	0.0341	CcSEcCtD
Quinidine—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00216	0.0326	CcSEcCtD
Quinidine—Uremia—Lisinopril—dilated cardiomyopathy	0.00215	0.0324	CcSEcCtD
Quinidine—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00186	0.0281	CcSEcCtD
Quinidine—Anuria—Lisinopril—dilated cardiomyopathy	0.00155	0.0234	CcSEcCtD
Quinidine—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00137	0.0207	CcSEcCtD
Quinidine—Quinine—SLC22A5—dilated cardiomyopathy	0.00129	0.315	CrCbGaD
Quinidine—KCNK1—cardiac ventricle—dilated cardiomyopathy	0.00124	0.0187	CbGeAlD
Quinidine—Drug eruption—Furosemide—dilated cardiomyopathy	0.00117	0.0177	CcSEcCtD
Quinidine—KCNK1—myocardium—dilated cardiomyopathy	0.00117	0.0176	CbGeAlD
Quinidine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00104	0.0158	CcSEcCtD
Quinidine—Azotaemia—Lisinopril—dilated cardiomyopathy	0.00102	0.0154	CcSEcCtD
Quinidine—Blindness—Lisinopril—dilated cardiomyopathy	0.000979	0.0148	CcSEcCtD
Quinidine—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.000943	0.0142	CcSEcCtD
Quinidine—Ataxia—Spironolactone—dilated cardiomyopathy	0.000906	0.0137	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000868	0.0131	CcSEcCtD
Quinidine—KCNK1—heart—dilated cardiomyopathy	0.000816	0.0123	CbGeAlD
Quinidine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000759	0.0115	CcSEcCtD
Quinidine—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.000742	0.0112	CbGeAlD
Quinidine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000736	0.0111	CcSEcCtD
Quinidine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00073	0.011	CcSEcCtD
Quinidine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000708	0.0107	CcSEcCtD
Quinidine—SCN5A—myocardium—dilated cardiomyopathy	0.000698	0.0105	CbGeAlD
Quinidine—KCNK1—cardiac atrium—dilated cardiomyopathy	0.000698	0.0105	CbGeAlD
Quinidine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000693	0.0105	CcSEcCtD
Quinidine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000678	0.0102	CcSEcCtD
Quinidine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00063	0.00952	CcSEcCtD
Quinidine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.0006	0.00906	CcSEcCtD
Quinidine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000597	0.00902	CcSEcCtD
Quinidine—Oliguria—Lisinopril—dilated cardiomyopathy	0.000588	0.00888	CcSEcCtD
Quinidine—Deafness—Furosemide—dilated cardiomyopathy	0.000586	0.00885	CcSEcCtD
Quinidine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000581	0.00877	CcSEcCtD
Quinidine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000556	0.00839	CcSEcCtD
Quinidine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000549	0.00829	CcSEcCtD
Quinidine—Purpura—Furosemide—dilated cardiomyopathy	0.000544	0.00822	CcSEcCtD
Quinidine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000542	0.00819	CcSEcCtD
Quinidine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00052	0.00785	CcSEcCtD
Quinidine—Photophobia—Lisinopril—dilated cardiomyopathy	0.000509	0.00769	CcSEcCtD
Quinidine—SCN3A—heart—dilated cardiomyopathy	0.000489	0.00735	CbGeAlD
Quinidine—SCN5A—heart—dilated cardiomyopathy	0.000487	0.00733	CbGeAlD
Quinidine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000482	0.00729	CcSEcCtD
Quinidine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000479	0.00723	CcSEcCtD
Quinidine—Confusional state—Spironolactone—dilated cardiomyopathy	0.000478	0.00721	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000472	0.00713	CcSEcCtD
Quinidine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000464	0.00701	CcSEcCtD
Quinidine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000463	0.00698	CcSEcCtD
Quinidine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.000456	0.00686	CbGeAlD
Quinidine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000448	0.00677	CcSEcCtD
Quinidine—Eczema—Lisinopril—dilated cardiomyopathy	0.000438	0.00661	CcSEcCtD
Quinidine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000436	0.00658	CcSEcCtD
Quinidine—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.000431	0.00648	CbGeAlD
Quinidine—KCNH2—myocardium—dilated cardiomyopathy	0.000429	0.00645	CbGeAlD
Quinidine—SLC22A4—heart—dilated cardiomyopathy	0.000428	0.00643	CbGeAlD
Quinidine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000426	0.00644	CcSEcCtD
Quinidine—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000417	0.00627	CbGeAlD
Quinidine—CHRM2—heart—dilated cardiomyopathy	0.000415	0.00624	CbGeAlD
Quinidine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000414	0.00625	CcSEcCtD
Quinidine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000413	0.00624	CcSEcCtD
Quinidine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000409	0.00618	CcSEcCtD
Quinidine—SLC22A5—myocardium—dilated cardiomyopathy	0.000406	0.0061	CbGeAlD
Quinidine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000403	0.00609	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000401	0.00605	CcSEcCtD
Quinidine—Renal failure—Furosemide—dilated cardiomyopathy	0.000397	0.006	CcSEcCtD
Quinidine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000393	0.00594	CcSEcCtD
Quinidine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00039	0.0059	CcSEcCtD
Quinidine—Sweating—Furosemide—dilated cardiomyopathy	0.000387	0.00585	CcSEcCtD
Quinidine—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000385	0.00579	CbGeAlD
Quinidine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000377	0.0057	CcSEcCtD
Quinidine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000376	0.00568	CcSEcCtD
Quinidine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000374	0.00566	CcSEcCtD
Quinidine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000374	0.00565	CcSEcCtD
Quinidine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00037	0.00559	CcSEcCtD
Quinidine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000359	0.00543	CcSEcCtD
Quinidine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000358	0.00541	CcSEcCtD
Quinidine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000356	0.00537	CcSEcCtD
Quinidine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000356	0.00537	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000354	0.00535	CcSEcCtD
Quinidine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00035	0.00528	CcSEcCtD
Quinidine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000349	0.00527	CcSEcCtD
Quinidine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000343	0.00518	CcSEcCtD
Quinidine—Asthma—Lisinopril—dilated cardiomyopathy	0.00034	0.00514	CcSEcCtD
Quinidine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000339	0.00512	CcSEcCtD
Quinidine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000338	0.00511	CcSEcCtD
Quinidine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000335	0.00506	CcSEcCtD
Quinidine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000334	0.00505	CcSEcCtD
Quinidine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000331	0.005	CcSEcCtD
Quinidine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000328	0.00495	CcSEcCtD
Quinidine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000324	0.0049	CcSEcCtD
Quinidine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000323	0.00488	CcSEcCtD
Quinidine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000318	0.0048	CcSEcCtD
Quinidine—Erythema—Furosemide—dilated cardiomyopathy	0.000316	0.00477	CcSEcCtD
Quinidine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000316	0.00477	CcSEcCtD
Quinidine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000313	0.00473	CcSEcCtD
Quinidine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00031	0.00469	CcSEcCtD
Quinidine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000301	0.00455	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000301	0.00454	CcSEcCtD
Quinidine—KCNH2—heart—dilated cardiomyopathy	0.0003	0.0045	CbGeAlD
Quinidine—Rash—Spironolactone—dilated cardiomyopathy	0.000299	0.00451	CcSEcCtD
Quinidine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000298	0.00451	CcSEcCtD
Quinidine—Renal failure—Lisinopril—dilated cardiomyopathy	0.000298	0.0045	CcSEcCtD
Quinidine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000298	0.00449	CcSEcCtD
Quinidine—Headache—Spironolactone—dilated cardiomyopathy	0.000297	0.00448	CcSEcCtD
Quinidine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000296	0.00446	CcSEcCtD
Quinidine—Sweating—Lisinopril—dilated cardiomyopathy	0.000291	0.00439	CcSEcCtD
Quinidine—Agitation—Furosemide—dilated cardiomyopathy	0.00029	0.00438	CcSEcCtD
Quinidine—Vertigo—Furosemide—dilated cardiomyopathy	0.000284	0.00429	CcSEcCtD
Quinidine—SLC22A5—heart—dilated cardiomyopathy	0.000283	0.00426	CbGeAlD
Quinidine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000283	0.00427	CcSEcCtD
Quinidine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000283	0.00427	CcSEcCtD
Quinidine—Nausea—Spironolactone—dilated cardiomyopathy	0.000281	0.00425	CcSEcCtD
Quinidine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000277	0.00418	CcSEcCtD
Quinidine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000272	0.00411	CcSEcCtD
Quinidine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000269	0.00406	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000267	0.00403	CcSEcCtD
Quinidine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000267	0.00403	CcSEcCtD
Quinidine—Confusional state—Furosemide—dilated cardiomyopathy	0.00026	0.00392	CcSEcCtD
Quinidine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000257	0.00389	CcSEcCtD
Quinidine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000256	0.00385	CbGeAlD
Quinidine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000254	0.00383	CcSEcCtD
Quinidine—Shock—Furosemide—dilated cardiomyopathy	0.000254	0.00383	CcSEcCtD
Quinidine—CYP1A1—heart—dilated cardiomyopathy	0.000253	0.0038	CbGeAlD
Quinidine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000253	0.00382	CcSEcCtD
Quinidine—Flushing—Lisinopril—dilated cardiomyopathy	0.000253	0.00382	CcSEcCtD
Quinidine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000252	0.00381	CcSEcCtD
Quinidine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00025	0.00378	CcSEcCtD
Quinidine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000249	0.00376	CcSEcCtD
Quinidine—CYP2B6—heart—dilated cardiomyopathy	0.000246	0.0037	CbGeAlD
Quinidine—Anorexia—Furosemide—dilated cardiomyopathy	0.000246	0.00371	CcSEcCtD
Quinidine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000245	0.0037	CcSEcCtD
Quinidine—Chills—Lisinopril—dilated cardiomyopathy	0.000244	0.00369	CcSEcCtD
Quinidine—CYP2C9—heart—dilated cardiomyopathy	0.000243	0.00366	CbGeAlD
Quinidine—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.000242	0.00364	CbGeAlD
Quinidine—Hypotension—Furosemide—dilated cardiomyopathy	0.000241	0.00364	CcSEcCtD
Quinidine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000238	0.0036	CcSEcCtD
Quinidine—Erythema—Lisinopril—dilated cardiomyopathy	0.000237	0.00358	CcSEcCtD
Quinidine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000237	0.00358	CcSEcCtD
Quinidine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000224	0.00338	CcSEcCtD
Quinidine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000223	0.00337	CcSEcCtD
Quinidine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000223	0.00336	CcSEcCtD
Quinidine—Tremor—Lisinopril—dilated cardiomyopathy	0.000222	0.00335	CcSEcCtD
Quinidine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000217	0.00327	CcSEcCtD
Quinidine—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000216	0.00325	CbGeAlD
Quinidine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000213	0.00322	CcSEcCtD
Quinidine—Syncope—Lisinopril—dilated cardiomyopathy	0.000212	0.00321	CcSEcCtD
Quinidine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000212	0.00321	CcSEcCtD
Quinidine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000212	0.0032	CcSEcCtD
Quinidine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000211	0.00318	CcSEcCtD
Quinidine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000209	0.00316	CcSEcCtD
Quinidine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000208	0.00315	CcSEcCtD
Quinidine—Urticaria—Furosemide—dilated cardiomyopathy	0.000205	0.00309	CcSEcCtD
Quinidine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000204	0.00308	CcSEcCtD
Quinidine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000204	0.00308	CcSEcCtD
Quinidine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000202	0.00305	CcSEcCtD
Quinidine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000202	0.00305	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.0002	0.00303	CcSEcCtD
Quinidine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000195	0.00294	CcSEcCtD
Quinidine—Oedema—Lisinopril—dilated cardiomyopathy	0.000193	0.00292	CcSEcCtD
Quinidine—Shock—Lisinopril—dilated cardiomyopathy	0.00019	0.00287	CcSEcCtD
Quinidine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00019	0.00287	CcSEcCtD
Quinidine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000189	0.00286	CcSEcCtD
Quinidine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000189	0.00285	CcSEcCtD
Quinidine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000188	0.00284	CcSEcCtD
Quinidine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000187	0.00282	CcSEcCtD
Quinidine—Asthenia—Furosemide—dilated cardiomyopathy	0.000185	0.00279	CcSEcCtD
Quinidine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000184	0.00278	CcSEcCtD
Quinidine—Pruritus—Furosemide—dilated cardiomyopathy	0.000182	0.00275	CcSEcCtD
Quinidine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000181	0.00273	CcSEcCtD
Quinidine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000176	0.00266	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000176	0.00266	CcSEcCtD
Quinidine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000172	0.0026	CcSEcCtD
Quinidine—Dizziness—Furosemide—dilated cardiomyopathy	0.00017	0.00257	CcSEcCtD
Quinidine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000168	0.00254	CcSEcCtD
Quinidine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000167	0.00252	CcSEcCtD
Quinidine—Vomiting—Furosemide—dilated cardiomyopathy	0.000164	0.00247	CcSEcCtD
Quinidine—Rash—Furosemide—dilated cardiomyopathy	0.000163	0.00245	CcSEcCtD
Quinidine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000162	0.00245	CcSEcCtD
Quinidine—Headache—Furosemide—dilated cardiomyopathy	0.000161	0.00244	CcSEcCtD
Quinidine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000159	0.00241	CcSEcCtD
Quinidine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000158	0.00239	CcSEcCtD
Quinidine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000154	0.00232	CcSEcCtD
Quinidine—Nausea—Furosemide—dilated cardiomyopathy	0.000153	0.00231	CcSEcCtD
Quinidine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000153	0.00231	CcSEcCtD
Quinidine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000153	0.00231	CcSEcCtD
Quinidine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000142	0.00215	CcSEcCtD
Quinidine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000139	0.0021	CcSEcCtD
Quinidine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000137	0.00207	CcSEcCtD
Quinidine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000132	0.002	CcSEcCtD
Quinidine—ABCB1—heart—dilated cardiomyopathy	0.000131	0.00198	CbGeAlD
Quinidine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000128	0.00193	CcSEcCtD
Quinidine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000123	0.00186	CcSEcCtD
Quinidine—Rash—Lisinopril—dilated cardiomyopathy	0.000122	0.00184	CcSEcCtD
Quinidine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000122	0.00184	CcSEcCtD
Quinidine—Headache—Lisinopril—dilated cardiomyopathy	0.000121	0.00183	CcSEcCtD
Quinidine—Nausea—Lisinopril—dilated cardiomyopathy	0.000115	0.00173	CcSEcCtD
Quinidine—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	4.25e-05	0.000954	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.19e-05	0.000942	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.16e-05	0.000935	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.08e-05	0.000916	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.08e-05	0.000916	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	4.08e-05	0.000916	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.07e-05	0.000914	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	4e-05	0.000899	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	4e-05	0.000898	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	3.99e-05	0.000896	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	3.95e-05	0.000887	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	3.93e-05	0.000884	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.92e-05	0.00088	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	3.85e-05	0.000864	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—SDHA—dilated cardiomyopathy	3.84e-05	0.000864	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	3.84e-05	0.000863	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.81e-05	0.000855	CbGpPWpGaD
Quinidine—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	3.8e-05	0.000855	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.79e-05	0.000852	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.77e-05	0.000848	CbGpPWpGaD
Quinidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	3.72e-05	0.000837	CbGpPWpGaD
Quinidine—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	3.72e-05	0.000835	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	3.71e-05	0.000833	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	3.71e-05	0.000833	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	3.65e-05	0.00082	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	3.59e-05	0.000807	CbGpPWpGaD
Quinidine—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	3.57e-05	0.000802	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	3.55e-05	0.000797	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	3.51e-05	0.000788	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	3.44e-05	0.000774	CbGpPWpGaD
Quinidine—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	3.43e-05	0.00077	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.42e-05	0.000768	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.42e-05	0.000768	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.39e-05	0.000761	CbGpPWpGaD
Quinidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	3.35e-05	0.000753	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.27e-05	0.000736	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.27e-05	0.000736	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.24e-05	0.000728	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.23e-05	0.000725	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	3.21e-05	0.000721	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.19e-05	0.000716	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	3.18e-05	0.000714	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.12e-05	0.000701	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.12e-05	0.000701	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	3.08e-05	0.000691	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	3.07e-05	0.000689	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.05e-05	0.000684	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	3.03e-05	0.000682	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	2.96e-05	0.000665	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.96e-05	0.000664	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	2.91e-05	0.000654	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.9e-05	0.000651	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.84e-05	0.000637	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	2.79e-05	0.000626	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	2.78e-05	0.000625	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	2.77e-05	0.000621	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.76e-05	0.000619	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.75e-05	0.000618	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	2.74e-05	0.000616	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.72e-05	0.000612	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	2.65e-05	0.000596	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	2.65e-05	0.000594	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.63e-05	0.000591	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	2.61e-05	0.000585	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.6e-05	0.000585	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.6e-05	0.000585	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	2.59e-05	0.000582	CbGpPWpGaD
Quinidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	2.57e-05	0.000576	CbGpPWpGaD
Quinidine—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	2.55e-05	0.000573	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	2.55e-05	0.000573	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	2.52e-05	0.000566	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	2.51e-05	0.000565	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.49e-05	0.00056	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.46e-05	0.000552	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	2.46e-05	0.000552	CbGpPWpGaD
Quinidine—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	2.45e-05	0.00055	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	2.42e-05	0.000544	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.42e-05	0.000544	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.39e-05	0.000537	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.39e-05	0.000537	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	2.36e-05	0.000531	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.34e-05	0.000527	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.34e-05	0.000527	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	2.34e-05	0.000527	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	2.33e-05	0.000523	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	2.32e-05	0.000522	CbGpPWpGaD
Quinidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	2.31e-05	0.000519	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.28e-05	0.000513	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.22e-05	0.000499	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	2.19e-05	0.000492	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.15e-05	0.000484	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	2.15e-05	0.000482	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.09e-05	0.000469	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.09e-05	0.000469	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	2.06e-05	0.000463	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.06e-05	0.000462	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.02e-05	0.000454	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	2.02e-05	0.000453	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.01e-05	0.000451	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2e-05	0.00045	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	1.99e-05	0.000447	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	1.99e-05	0.000447	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.96e-05	0.00044	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.95e-05	0.000438	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.91e-05	0.000428	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	1.9e-05	0.000427	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.9e-05	0.000427	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.88e-05	0.000422	CbGpPWpGaD
Quinidine—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.88e-05	0.000422	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	1.86e-05	0.000418	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	1.85e-05	0.000417	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.85e-05	0.000416	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.84e-05	0.000414	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	1.82e-05	0.00041	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	1.82e-05	0.000409	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	1.75e-05	0.000393	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	1.74e-05	0.000392	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	1.73e-05	0.000389	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	1.73e-05	0.000388	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	1.72e-05	0.000386	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.72e-05	0.000386	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	1.69e-05	0.000379	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.67e-05	0.000376	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	1.66e-05	0.000374	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	1.66e-05	0.000373	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	1.65e-05	0.000371	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.63e-05	0.000366	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.62e-05	0.000363	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.62e-05	0.000363	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	1.61e-05	0.000361	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	1.59e-05	0.000358	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.58e-05	0.000354	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	1.54e-05	0.000346	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.52e-05	0.000342	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.52e-05	0.000341	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.51e-05	0.000339	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.47e-05	0.00033	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.47e-05	0.00033	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.47e-05	0.00033	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.46e-05	0.000329	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.43e-05	0.000322	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.42e-05	0.000319	CbGpPWpGaD
Quinidine—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.41e-05	0.000317	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	1.41e-05	0.000316	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.37e-05	0.000309	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.37e-05	0.000307	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.34e-05	0.0003	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.34e-05	0.0003	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.32e-05	0.000298	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.29e-05	0.000291	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.29e-05	0.00029	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.28e-05	0.000288	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.28e-05	0.000287	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.24e-05	0.000279	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.22e-05	0.000274	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.21e-05	0.000272	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.2e-05	0.00027	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	1.18e-05	0.000266	CbGpPWpGaD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.13e-05	0.000254	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.13e-05	0.000254	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	1.13e-05	0.000253	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.1e-05	0.000246	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.07e-05	0.000241	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.05e-05	0.000236	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—GPX1—dilated cardiomyopathy	1.04e-05	0.000235	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.03e-05	0.000232	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.03e-05	0.000231	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.02e-05	0.00023	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CD36—dilated cardiomyopathy	1.02e-05	0.000228	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	9.95e-06	0.000224	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.75e-06	0.000219	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.69e-06	0.000218	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.62e-06	0.000216	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.37e-06	0.00021	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	9.36e-06	0.00021	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.2e-06	0.000207	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AGT—dilated cardiomyopathy	9.16e-06	0.000206	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.89e-06	0.0002	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.88e-06	0.000199	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	8.72e-06	0.000196	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	8.49e-06	0.000191	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.46e-06	0.00019	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.43e-06	0.000189	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.37e-06	0.000188	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.33e-06	0.000187	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.27e-06	0.000186	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.98e-06	0.000179	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.96e-06	0.000179	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.89e-06	0.000177	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.89e-06	0.000177	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.83e-06	0.000176	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	7.64e-06	0.000172	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.62e-06	0.000171	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.57e-06	0.00017	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	7.45e-06	0.000167	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.34e-06	0.000165	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	7.26e-06	0.000163	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	7.23e-06	0.000162	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.11e-06	0.00016	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.86e-06	0.000154	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	6.84e-06	0.000154	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	6.83e-06	0.000153	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.69e-06	0.00015	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	6.66e-06	0.00015	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	6.65e-06	0.000149	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	6.54e-06	0.000147	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.52e-06	0.000146	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	6.37e-06	0.000143	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	6.2e-06	0.000139	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.07e-06	0.000136	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	6e-06	0.000135	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	5.99e-06	0.000135	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.87e-06	0.000132	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.76e-06	0.000129	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	5.58e-06	0.000125	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	5.06e-06	0.000114	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.02e-06	0.000113	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	4.96e-06	0.000111	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.95e-06	0.000111	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	4.93e-06	0.000111	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.85e-06	0.000109	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	4.83e-06	0.000108	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	4.67e-06	0.000105	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	4.55e-06	0.000102	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.47e-06	0.0001	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	4.44e-06	9.97e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	4.35e-06	9.76e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	4.28e-06	9.62e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	4.27e-06	9.59e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	4.17e-06	9.37e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	4.1e-06	9.2e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.76e-06	8.44e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.73e-06	8.38e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.63e-06	8.16e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.52e-06	7.9e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.49e-06	7.83e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.44e-06	7.73e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.43e-06	7.69e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.4e-06	7.63e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.27e-06	7.35e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.08e-06	6.93e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.06e-06	6.87e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.98e-06	6.69e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.96e-06	6.66e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.9e-06	6.52e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.61e-06	5.87e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.3e-06	5.17e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.24e-06	5.03e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.03e-06	4.57e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.02e-06	4.53e-05	CbGpPWpGaD
